Snapshot from Jul 07, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Elanco / Zoetis

Elanco & Zoetis

2 shared events · Importance 3 · Last updated Jul 02, 2026

Importance
3
Shared Events
2
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (2)
63
Business
Zoetis Securities Fraud Class Actions
Elanco: Elanco is a competitor to Zoetis, with its products Credelio Quattro and Ilunocitinib gaining market share from Zoetis' key companion animal products.
Zoetis: Zoetis is facing a class action lawsuit for alleged securities fraud and unlawful business practices, which has negatively impacted its stock price and reputation. The company also cut its full-year 2026 profit guidance due to a challenging operating environment.
May 18, 2026 · 251 articles
20
International
AI Stock Sell-off, Iran War
Elanco: Elanco rose 1.5% on expectations for stronger profits following the confirmation of the New World screwworm fly in south Texas.
Zoetis: Zoetis climbed due to expectations of stronger profits after the detection of the New World screwworm fly, increasing demand for animal vaccines.
Jun 03, 2026 · 191 articles
NEWSDESK
Explore this relationship live

Track how Elanco and Zoetis interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.